Frankfurt - Delayed Quote EUR
Ascentage Pharma Group International (36X.F)
5.05
+0.29
+(6.09%)
As of 9:59:02 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-712,004
-726,077
-653,915
-604,679
-609,956
Investing Cash Flow
-44,582
21,922
-384,612
-466,522
-107,367
Financing Cash Flow
310,023
368,751
619,268
1,781,387
1,040,003
End Cash Position
943,428
1,038,048
1,345,639
1,706,886
1,019,979
Capital Expenditure
-38,588
-56,844
-236,963
-436,629
-251,476
Issuance of Capital Stock
533,945
470,089
19
1,300,645
634,217
Issuance of Debt
209,417
953,500
763,617
599,737
527,805
Repayment of Debt
-339,884
-956,091
-54,504
-51,150
-95,000
Repurchase of Capital Stock
-7,882
-5,923
-26,776
-25,874
--
Free Cash Flow
-750,592
-782,921
-890,878
-1,041,308
-861,432
12/31/2020 - 12/20/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2160.T GNI Group Ltd.
2,200.00
+0.46%
GYRE Gyre Therapeutics, Inc.
9.48
+9.72%
IMAB I-Mab
0.8627
+3.85%
ERAS Erasca, Inc.
1.5200
+10.14%
PULM Pulmatrix, Inc.
6.56
+2.50%
OLMA Olema Pharmaceuticals, Inc.
5.06
+2.02%
LEGN Legend Biotech Corporation
35.15
+1.93%
ONC BeiGene, Ltd.
254.13
+0.54%
APLS Apellis Pharmaceuticals, Inc.
18.21
+4.84%
IBRX ImmunityBio, Inc.
2.8500
+5.94%